• Wnt-C59: PORCN Inhibitor Workflow Guide

  2026-09-14

  Wnt-C59 provides a ligand-focused way to test PORCN-dependent Wnt signaling, from TCF reporter assays and cholangiocarcinoma phenotyping to exploratory exosome studies. This guide translates its potency, formulation, and mechanism into practical workflows while defining controls that prevent overinterpreting Wnt secretion or β-catenin responses.

• Lithium, Exosomal Wnt10a, and Bone Repair

  2026-09-13

  This 2024 ACS Applied Materials & Interfaces study identifies a Rab11a–Rab11FIP1 trafficking mechanism through which lithium increases exosomal Wnt10a secretion from bone mesenchymal stem cells. Lithium-conditioned exosomes enhanced osteogenic differentiation, while their incorporation into GelMA hydrogels improved bone repair and provided a mechanistic framework for cell-free regenerative therapy.

• Beclin1, Ferroptosis, and Doxorubicin Liver Injury

  2026-09-12

  The reference study identifies Beclin1 as a promoter of doxorubicin-induced liver injury by linking it to ferroptosis, oxidative stress, and excessive autophagy. Its results position DHODH as a protective downstream component and show why coordinated measurement of malondialdehyde, lipid peroxidation, iron, and ferroptosis-related proteins is important for mechanistic interpretation.

• CGRP/SP–Piezo2 Signaling in Trigeminal Neuralgia

  2026-09-11

  Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. The study combines a rat trigeminal neuralgia model with behavioral, tissue, knockdown, and cell-based experiments to define how ATP, PKC, ERK1/2, and p38 MAPK signaling may amplify abnormal facial mechanosensitivity.

• Roxadustat and the HIF-α/GATA1 Erythroid Axis

  2026-09-11

  The reference study shows that roxadustat promotes erythroid differentiation in HEL and K562 erythroleukemia cells through hypoxia-inducible factor signaling, with HIF-2α and GATA1 providing key mechanistic nodes. Its combination results with ruxolitinib or Imatinib suggest a context-dependent strategy for studying erythroid maturation and leukemia-associated signaling, while the mechanistic and translational boundaries remain important.

• Sodium Orthovanadate in Phosphorylation Assays

  2026-09-10

  Sodium Orthovanadate (Na3VO4) is more than a routine phosphatase blocker. This guide explains how its reversible, broad enzyme inhibition can preserve signaling information while also shaping assay interpretation, with practical insights from adipocyte insulin-signaling research.

• QNZ (EVP4593) in NF-κB Research Workflows

  2026-09-10

  QNZ (EVP4593) combines nanomolar NF-κB pathway inhibition with practical utility in inflammatory, neuronal, and reporter-based assays. This workflow-focused guide connects pathway suppression to HEV host-response research while emphasizing controls, solubility management, and interpretation limits.

• Cy5 maleimide for Protein Labeling and LLPS

  2026-09-09

  Cy5 maleimide enables cysteine-selective, far-red protein labeling for microscopy, readers, and condensate partitioning assays. This guide pairs a solvent-aware conjugation workflow with α-synuclein electrostatics findings while showing how to distinguish true molecular partitioning from dye-induced artifacts.

• Surface-Cleaned Black Phosphorus in Acute Kidney Injury

  2026-09-09

  A 2026 Theranostics study shows that hydrogen-reduced, surface-cleaned black phosphorus nanosheets can accumulate in injured kidneys, chelate labile iron, suppress ferroptosis, and reduce macrophage-driven inflammation. The work is notable because it connects nanomaterial surface chemistry with coordinated control of tubular oxidative injury and immune amplification, while also providing a multi-level framework for evaluating iron-dependent kidney damage.

• AZD1390: ATM Kinase Inhibitor for Radiosensitization

  2026-09-09

  AZD1390 is a potent ATM kinase inhibitor that suppresses DNA damage response signaling in cellular assays. Its nanomolar activity and radiation-enhanced effects support cancer research focused on glioblastoma radiosensitization, lung cancer models, and ATM-dependent checkpoint biology.

• H 89 2HCl in D2-MSN Signaling Assays

  2026-09-08

  H 89 2HCl enables controlled interrogation of PKA signaling without confusing kinase activity with cAMP production. This guide connects its assay profile with recent D2-MSN and autism-related circuit research, emphasizing interpretation, controls, and experimental boundaries.

• QNZ (EVP4593) NF-κB Research Workflows

  2026-09-07

  QNZ (EVP4593) combines nanomolar NF-κB pathway inhibition with practical applications in inflammatory signaling and Huntington’s disease research. This workflow-oriented guide covers dose finding, reporter and TNF-α validation, calcium-flux studies, solubility control, and troubleshooting for more reproducible results.

• Tomivosertib: MNK1 Inhibitor Workflow Guide

  2026-09-07

  Tomivosertib enables selective interrogation of MNK1/2-driven eIF4E phosphorylation in cancer, endothelial, neuronal, and metabolic models. This practical guide connects target-engagement assays with angiogenesis, apoptosis, chemotherapy-sensitization, and troubleshooting workflows.

• Erastin: A Practical Ferroptosis Inducer Workflow

  2026-09-05

  Build a controlled ferroptosis workflow with Erastin by combining genotype-aware cell selection, fresh DMSO preparation, orthogonal oxidative-stress readouts, and rescue controls. The approach supports both cancer biology research and mechanistic studies inspired by evidence linking ferroptosis to cisplatin-induced kidney injury.

• Flubendazole: Reliable Autophagy Assays

  2026-09-04

  Learn how Flubendazole (SKU B1759) can support better-controlled cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent handling, assay design, protocol parameters, metabolic confounding, and practical supplier selection.

8535 records 1/569 page Next 12345 下5页 Last page